Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
US7332182B2 · kind B2 · utility
254Cited by
14References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 6, 2002 |
| Grant date | Feb 19, 2008 |
| Priority date | — |
| Expiry date | May 20, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/2027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed in certain embodiments is an oral dosage form comprising:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.